KÜRTÜNCÜ, M. Et Al. 2013. Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients. 29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) .

KÜRTÜNCÜ, M., TÜZÜN, E., Balcı, B., Birday, E., ÇOBAN, A., Türkoğlu, R., ... İçöz, S.(2013). Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients . 29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS)

KÜRTÜNCÜ, Murat Et Al. "Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients," 29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 2013

KÜRTÜNCÜ, Murat Et Al. "Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients." 29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) , 2013

KÜRTÜNCÜ, M. Et Al. (2013) . "Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients." 29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) .

@conferencepaper{conferencepaper, author={Murat KÜRTÜNCÜ Et Al. }, title={Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients}, congress name={29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS)}, city={}, country={}, year={2013}}